Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2 Negative Breast Cancer × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 34 Pancreatic Neoplasms 14 Breast Neoplasms 13 Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Rectal Neoplasms 10 Triple Negative Breast Neoplasms 9 Nasopharyngeal Carcinoma 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 Stomach Neoplasms 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Uterine Cervical Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 7 Small Cell Lung Carcinoma 6 Sarcoma 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 NSCLC 4 Endometrial Neoplasms 4 Recurrence 3 Glioma 3 Colonic Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Thymoma 2 Sarcoma, Ewing 2 Prostatic Neoplasms 2

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡